コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 iotics are really needed in the treatment of acute otitis media.
2 with clinical signs of meningitis following acute otitis media.
3 l outcomes including all-cause pneumonia and acute otitis media.
4 y-tube placement for children with recurrent acute otitis media.
5 ociated with GAS pharyngitis, sinusitis, and acute otitis media.
6 antimicrobial resistance among children with acute otitis media.
7 hus increase the risk of clinically relevant acute otitis media.
8 or children younger than 2 years of age with acute otitis media.
9 nes broadens and enhances protection against acute otitis media.
10 virus were not significantly associated with acute otitis media.
11 se compared with nonbacteremic pneumonia and acute otitis media.
12 se of observation in children diagnosed with acute otitis media.
13 possible role in middle ear survival and/or acute otitis media.
14 f of middle ear aspirates from children with acute otitis media.
15 he HMW adhesins may be virulence factors for acute otitis media.
16 le ear mucosa contributes to the sequelae of acute otitis media.
17 by nontypeable Haemophilus influenzae during acute otitis media.
18 raxella catarrhalis, is a causative agent of acute otitis media.
19 children whose only indication is recurrent acute otitis media.
20 ruses may be able to reduce the frequency of acute otitis media.
21 ildren (age, two months to seven years) with acute otitis media.
22 incipal virus invading the middle ear during acute otitis media.
23 typeable H. influenzae from 17 children with acute otitis media.
24 great impact on the antibiotic treatment of acute otitis media.
25 ntrol group: mean annual rate of episodes of acute otitis media, 1.4 vs 2.1 (P<.001); and mean estima
26 dren in the retrospective cohort (19179 with acute otitis media; 6746, group A streptococcal pharyngi
27 nrolled in the prospective cohort (1100 with acute otitis media; 705, group A streptococcal pharyngit
31 n with symptoms of influenza, 46 episodes of acute otitis media, and 8 episodes of lower respiratory
33 ncy and duration of colonization and risk of acute otitis media (AOM) and otitis media with effusion
41 r fluid (MEF) isolates collected at onset of acute otitis media (AOM) in Rochester, New York, were co
42 prescribing for pharyngitis, sinusitis, and acute otitis media (AOM) in the United States using nati
51 eal swabs were obtained from patients during acute otitis media (AOM) visits and routine healthy visi
53 ions (URIs) are common and often precipitate acute otitis media (AOM), caused by bacterial otopathoge
55 defense against Streptococcus pneumoniae in acute otitis media (AOM), we investigated the susceptibi
56 jugate vaccine trial FinOM for prevention of acute otitis media (AOM), with a focus on disease replac
62 bution and proportions of pneumococcal ARIs (acute otitis media [AOM; children only], sinusitis, nonb
66 icated acute otitis media (uAOM) and complex acute otitis media (cAOM) over 3 timeframes: 2006-2009 (
67 . pneumoniae, engendering protection against acute otitis media caused by emerging unencapsulated oto
68 specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract
70 hether viral load plays an important role in acute otitis media development, but symptomatic upper re
72 ned 291 children 6 to 23 months of age, with acute otitis media diagnosed with the use of stringent c
73 An increasing proportion of children with acute otitis media due to Streptococcus pneumoniae have
74 coccal isolates recovered from children with acute otitis media during 1 January-31 December 1999 and
75 acute otitis media, the rate of episodes of acute otitis media during a 2-year period was not signif
76 of nontypeable H. influenzae associated with acute otitis media express HMW1/HMW2-like proteins, with
77 rs effective protection against pneumococcal acute otitis media for non-PCV-13 serotypes and enhances
78 ibility of children to recurrent episodes of acute otitis media (hereafter, "otitis-prone children").
79 pathogen known for being a frequent cause of acute otitis media in children and respiratory tract inf
80 n, these organisms have an important role in acute otitis media in children as well as other respirat
86 Moraxella catarrhalis is a major cause of acute otitis media in young children and has also been i
88 We review the contemporary management of acute otitis media, including symptomatic care, the rati
91 f respiratory viruses in the pathogenesis of acute otitis media is well established, the relative imp
98 and non-otitis-prone children at the time of acute otitis media or nasopharyngeal colonization with S
101 y outcome was the mean number of episodes of acute otitis media per child-year (rate) during a 2-year
102 reat analysis, the rate ( SE) of episodes of acute otitis media per child-year during a 2-year period
103 plicated upper respiratory tract encounters (acute otitis media, pharyngitis, sinusitis, presumed vir
104 US children (<=17 years) from 2016-2019 for acute otitis media, pneumonia, and sinusitis associated
105 ed bacterial carriage and complications such acute otitis media, pneumonia, bacteremia, and meningiti
106 significant associations between each cold, acute otitis media, pneumonia, gastroenteritis, and feve
108 Among children 6 to 23 months of age with acute otitis media, reduced-duration antimicrobial treat
110 Among the types of viruses associated with acute otitis media, respiratory syncytial virus continue
112 r the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk
113 cteria, and acute otitis media risk factors, acute otitis media risk was independently associated wit
115 t cause of respiratory infections, including acute otitis media, sinusitis, and chronic bronchitis, w
119 ed the frequency distribution of episodes of acute otitis media, the percentage of episodes considere
120 hildren 6 to 35 months of age with recurrent acute otitis media, the rate of episodes of acute otitis
121 pathogen that causes infections ranging from acute otitis media to life-threatening invasive disease.
122 rum of clinical syndromes from uncomplicated acute otitis media to more complex recurrent and chronic
123 ed 520 children, 6 to 23 months of age, with acute otitis media to receive amoxicillin-clavulanate ei
124 egistered common infection episodes of cold, acute otitis media, tonsillitis, pneumonia, gastroenteri
125 Among children 6 to 23 months of age with acute otitis media, treatment with amoxicillin-clavulana
126 eptibility among children with uncomplicated acute otitis media (uAOM) and complex acute otitis media
127 lacement were the time to a first episode of acute otitis media, various episode-related clinical fin
128 fluenzae nasopharyngeal colonization than in acute otitis media whereas the HMW adhesins may be virul
129 subjects were eligible because of recurrent acute otitis media, with or without persistent otitis me
130 f age who had had at least three episodes of acute otitis media within 6 months, or at least four epi